The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Ikonomov, O. C.
* Articles by Manji, H. K.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Ikonomov, O. C.
* Articles by Manji, H. K.
Related Collections
* Neurotransmitters
* Bipolar Disorder
* Lithium
* Genetics
* Molecular Biology
Am J Psychiatry 156:1506-1514, October 1999
© 1999 American Psychiatric Association


Special Article

Molecular Mechanisms Underlying Mood Stabilization in Manic-Depressive Illness: The Phenotype Challenge

Ognian C. Ikonomov, M.D., Ph.D., and Husseini K. Manji, M.D.

OBJECTIVE: The authors critically examine the evidence supporting the hypothesis that lithium's therapeutic effects in bipolar affective disorder are mediated by alterations in the expression of specific genes in critical neuronal circuits. METHOD: Using the heuristic "initiation and adaptation paradigm," the authors appraise the biological effects and underlying molecular and cellular mechanisms of lithium's action. The evidence is critically reviewed, with special attention to the reductive and integrative approaches necessary for identifying lithium's clinically relevant cellular and molecular targets. RESULTS: Lithium's acute effects are mediated through inhibition of specific enzymes involved in two distinct but interacting signaling pathways—the protein kinase C and glycogen synthase kinase 3ß signaling ­cascades—that converge at the level of gene transcriptional regulation. The expression of different genes, including transcription factors, is markedly altered by chronic lithium administration. Chronic lithium treatment also robustly increases the expression of the neuroprotective protein Bcl-2, raising the intriguing possibility that some of lithium's effects are mediated through underappreciated neurotrophic/neuroprotective effects. The importance of lithium's effect on circadian rhythms and the related methodological problems in validating the role of specific genes in lithium's therapeutic effects are discussed. CONCLUSIONS: Despite the plethora of lithium effects at the genomic level, direct evidence that the genes identified thus far are responsible for phenotypic changes associated with chronic lithium treatment is still lacking. The combination of sensitive molecular technologies, appropriately designed paradigms, better behavioral analysis, and a chronobiologic approach seems necessary for the future identification of one or more clinically relevant lithium-­target genes.




This article has been cited by other articles:


Home page
Mol. Cell. ProteomicsHome page
Z. Wang, A. Pandey, and G. W. Hart
Dynamic Interplay between O-Linked N-Acetylglucosaminylation and Glycogen Synthase Kinase-3-dependent Phosphorylation
Mol. Cell. Proteomics, August 1, 2007; 6(8): 1365 - 1379.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Roberts, A. C. Scott, M. R. Howard, G. Breen, V. J. Bubb, E. Klenova, and J. P. Quinn
Differential Regulation of the Serotonin Transporter Gene by Lithium Is Mediated by Transcription Factors, CCCTC Binding Protein and Y-Box Binding Protein 1, through the Polymorphic Intron 2 Variable Number Tandem Repeat
J. Neurosci., March 14, 2007; 27(11): 2793 - 2801.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
C. Konradi, M. Eaton, M. L. MacDonald, J. Walsh, F. M. Benes, and S. Heckers
Molecular Evidence for Mitochondrial Dysfunction in Bipolar Disorder
Arch Gen Psychiatry, March 1, 2004; 61(3): 300 - 308.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. G. Banerjee, I. Bhattacharyya, W. M. Lydiatt, and J. K. Vishwanatha
Aberrant Expression and Localization of Decorin in Human Oral Dysplasia and Squamous Cell Carcinoma
Cancer Res., November 15, 2003; 63(22): 7769 - 7776.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
T. D. Gould and H. K. Manji
The Wnt Signaling Pathway in Bipolar Disorder
Neuroscientist, October 1, 2002; 8(5): 497 - 511.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
J. Carmichael, K. L. Sugars, Y. P. Bao, and D. C. Rubinsztein
Glycogen Synthase Kinase-3beta Inhibitors Prevent Cellular Polyglutamine Toxicity Caused by the Huntington's Disease Mutation
J. Biol. Chem., September 6, 2002; 277(37): 33791 - 33798.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
H. K. MANJI, G. J. MOORE, and G. CHEN
Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilisers
The British Journal of Psychiatry, June 1, 2001; 178 (41): s107 - s119.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. D. Mao, P. Hoang, and P. E. DiCorleto
Lithium Inhibits Cell Cycle Progression and Induces Stabilization of p53 in Bovine Aortic Endothelial Cells
J. Biol. Chem., July 6, 2001; 276(28): 26180 - 26188.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1999 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org